Search

Author/Creator Ali, Izna

3. Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS‐CoV‐2 neutralizing monoclonal antibody ABBV‐47D11 in patients with COVID‐19. Issue 1 (20th December 2022)

Authors:
Shebley, Mohamad; Wang, Stanley; Ali, Izna; Krishnan, Preethi; Tripathi, Rakesh; Reardon, Joseph M.; Cafardi, John; Rahav, Galia; Caraco, Yoseph; Slim, Jihad; Al Akhrass, Fadi; Yu, Mengjia; Hu, Yiran; Ferreira, Rosa De Abreu; Alami, Negar N.
Journal:
Pharmacology research & perspectives
Issue:
Volume 11:Issue 1(2023)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Transporter‐Mediated Alterations in Patients With NASH Increase Systemic and Hepatic Exposure to an OATP and MRP2 Substrate. Issue 4 (2nd February 2018)

Authors:
Ali, Izna; Slizgi, Jason R.; Kaullen, Josh D.; Ivanovic, Marija; Niemi, Mikko; Stewart, Paul W.; Barritt, Alfred S.; Brouwer, Kim L.R.
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 104:Issue 4(2018)
Page Start:
749
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗